Twinning and Risk of Stillbirth Subtypes in Pediatric Mothers

AbstractWe sought to estimate levels of risk for stillbirth subtypes associated with twin gestations among pediatric mothers (10–14 years). Analysis was on twin pregnancies covering the period 1989 to 2000 in the United States. We classified stillbirth as term, preterm, small-for-gestational-age (SGA) or preterm-SGA. We then assessed the risks of these stillbirth subtypes in pediatric mothers using two comparison groups consisting of women aged 15 to 19 years old (adolescent mothers) and 20 to 24 years old (mature mothers). Adjusted risk estimates were by means of hazard ratios generated from a Cox proportional hazards regression model. We adjusted for dependence of observations within twin clusters using the robust sandwich estimator. The rate of stillbirth was highest among pediatric mothers (56/1000), followed by adolescent gravidas (29/1000) and lowest in mature mothers (20/1000; p for trend < .01). Overall, preterm stillbirth was the most frequent stillbirth phenotype while term stillbirth was the least frequent. Not a single case of term stillbirth was recorded in pediatric mothers. Among pediatric gravidas, the risk for preterm stillbirth was more than tripled (adjusted hazard ratio [AHR] = 3.4; 95% confidence interval [CI] = 2.5–4.6), and that of preterm-SGA stillbirth more than doubled (AHR = 2.6; 95% CI = 1.8–3.7) that of mature mothers respectively. The 30% risk elevation for SGA stillbirth among pediatric mothers was not found to be statistically significant (AHR = 1.1; 95% CI = 0.3–4.3). Pediatric motherhood is a risk factor for stillbirth in twin gestation, especially, preterm and preterm-SGA stillbirth phenotypes. Prevention of stillbirth among this category of mothers should target the period preceding full term.

Download Full-text

Sex-Specific Associations between Blood Pressure and Risk of Atrial Fibrillation Subtypes in the Tromsø Study

Journal of Clinical Medicine ◽

10.3390/jcm10071514 ◽

2021 ◽

Vol 10 (7) ◽

pp. 1514

Author(s):

Hilde Espnes ◽

Jocasta Ball ◽

Maja-Lisa Løchen ◽

Tom Wilsgaard ◽

Inger Njølstad ◽

...

Keyword(s):

Atrial Fibrillation ◽

Blood Pressure ◽

Proportional Hazards ◽

Cox Proportional Hazards ◽

Pressure Management ◽

Reference Models ◽

Proportional Hazards Regression ◽

Hazard Ratios ◽

Increased Risk

The aim of this study was to explore sex-specific associations between systolic blood pressure (SBP), hypertension, and the risk of incident atrial fibrillation (AF) subtypes, including paroxysmal, persistent, and permanent AF, in a general population. A total of 13,137 women and 11,667 men who participated in the fourth survey of the Tromsø Study (1994–1995) were followed up for incident AF until the end of 2016. Cox proportional hazards regression analysis was conducted using fractional polynomials for SBP to provide sex- and AF-subtype-specific hazard ratios (HRs) for SBP. An SBP of 120 mmHg was used as the reference. Models were adjusted for other cardiovascular risk factors. Over a mean follow-up of 17.6 ± 6.6 years, incident AF occurred in 914 (7.0%) women (501 with paroxysmal/persistent AF and 413 with permanent AF) and 1104 (9.5%) men (606 with paroxysmal/persistent AF and 498 with permanent AF). In women, an SBP of 180 mmHg was associated with an HR of 2.10 (95% confidence interval [CI] 1.60–2.76) for paroxysmal/persistent AF and an HR of 1.80 (95% CI 1.33–2.44) for permanent AF. In men, an SBP of 180 mmHg was associated with an HR of 1.90 (95% CI 1.46–2.46) for paroxysmal/persistent AF, while there was no association with the risk of permanent AF. In conclusion, increasing SBP was associated with an increased risk of both paroxysmal/persistent AF and permanent AF in women, but only paroxysmal/persistent AF in men. Our findings highlight the importance of sex-specific risk stratification and optimizing blood pressure management for the prevention of AF subtypes in clinical practice.

Download Full-text

Consumption of flavonoid-rich fruits, flavonoids from fruits, and stroke risk: a prospective cohort study

British Journal Of Nutrition ◽

10.1017/s0007114521000404 ◽

2021 ◽

pp. 1-26

Author(s):

Qi Gao ◽

Jia-Yi Dong ◽

Renzhe Cui ◽

Isao Muraki ◽

Kazumasa Yamagishi ◽

...

Keyword(s):

Lower Risk ◽

Stroke Risk ◽

Proportional Hazards ◽

Cox Proportional Hazards ◽

Dietary Factors ◽

Citrus Fruits ◽

Proportional Hazards Regression ◽

Hazard Ratios ◽

Index Study

Abstract We sought to examine the prospective associations of specific fruit consumption, in particular flavonoid-rich fruit (FRF) consumption, with the risk of stroke and subtypes of stroke in a Japanese population. A study followed a total of 39,843 men and 47,334 women aged 44-76 years, and free of cardiovascular disease, diabetes, and cancer at baseline since 1995 and 1998 to the end of 2009 and 2012, respectively. Data on total and specific FRF consumption for each participant were obtained using a self-administrated food frequency questionnaire. The hazard ratios (HRs) of stroke in relation to total and specific FRF consumption were estimated through Cox proportional hazards regression models. During a median follow-up of 13.1 years, 4092 incident stroke cases (2557 cerebral infarctions and 1516 hemorrhagic strokes) were documented. After adjustment for age, body mass index, study area, lifestyles, dietary factors, and other risk factors, it was found that total FRF consumption was associated with a significantly lower risk of stroke in women (HR= 0.70; 95% CI, 0.58-0.84), while the association in men was not significant (HR= 0.93; 95% CI, 0.79-1.09). As for specific FRFs, consumptions of citrus fruits, strawberries, and grapes were found associated with a lower stroke risk in women. Higher consumptions of FRFs, in particular citrus fruits, strawberries, and grapes, were associated with a lower risk of developing stroke in Japanese women.

Download Full-text

Fibroblast growth factor receptor alteration (FGFRa) status and progression outcomes of patients with advanced or metastatic urothelial cancer (mUC).

Journal of Clinical Oncology ◽

10.1200/jco.2021.39.15_suppl.4530 ◽

2021 ◽

Vol 39 (15_suppl) ◽

pp. 4530-4530

Author(s):

Sarah Fleming ◽

Dina Gifkins ◽

Waleed Shalaby ◽

Jianjun Gao ◽

Philip Rosenberg ◽

...

Keyword(s):

Proportional Hazards ◽

The United States ◽

Cox Proportional Hazards ◽

Small Sample ◽

Prognostic Impact ◽

Patient Records ◽

Front Line ◽

Convenience Sample ◽

Adjusted Risk ◽

Metastatic Urothelial Cancer

4530 Background: FGFRa appear in approximately 15% of cases of mUC. Data on whether FGFRa in mUC have a prognostic impact or predictive benefit for particular treatments have been limited by small sample sizes. The objective of this study was to evaluate the association between tumor FGFRa and clinical outcomes of patients with advanced UC or mUC regardless of therapy type and status. Methods: A convenience sample of oncologists and urologists across the United States provided patient level data on 400 patients with stage IIIb or IV UC via a standardized questionnaire over a 1-month period (August 17, 2020 – September 20, 2020). Study design enriched for FGFRa by requiring physicians to provide ≥1 FGFRa patient record. The questionnaire included physician characteristics, patient demographic information, FGFR status, therapy given, response, and clinical and radiographic measures of progression. Patient records were eligible for inclusion if they were identified and treated during July 1, 2017, to June 30, 2019. Cox proportional hazards models were used to estimate adjusted risk of disease progression by FGFR status. Results: A total of 104 physicians (58.7% medical oncologists, 31.7% hematologic oncologists, and 9.6% urologic oncologists) contributed 414 patient records Overall, 73.9% of the patients were male and the average age was 64.5 years (SD ±10.6). Median follow-up was 15 months. Of the 414 patients, 218 (52.7%) had FGFRa and 196 (47.3%) had FGFR wild-type ( FGFRwt) mUC . Of the 218 patients with FGFRa, 47.2% were treated with front-line chemo, 27.5% with a programmed death-ligand 1 inhibitor (PD-L1), 11.5% with chemo + PD-L1, and 13.8% with other treatments. Of the 196 FGFRwt patients, 63.2% were treated with front-line chemo, 21.9% with PD-L1, 12.2% with chemo + PD-L1, and 2.6% with other treatments. There was no difference in response or progression status for those receiving front-line chemo (HR, 1.15; 95% CI, 0.86-1.55). Among 97 patients (55 FGFRa and 42 FGFRwt) who received PD-L1 alone as front-line therapy, those who had FGFRa had an adjusted risk of progression 2 times higher than their FGFRwt counterparts (HR, 2.12; 95% CI, 1.13-4.00). Conclusions: Patients with FGFRa mUC progressed earlier than FGFRwt patients treated with front-line PDL-1 inhibitors; however, there was no difference in progression in patients treated with chemo based upon FGFR status. This real-world study using a survey design efficiently generated a relatively large FGFRa dataset, mitigating a core limitation of other studies assessing the patient population with FGFRa. Further work is warranted to validate these results and determine the optimal strategy for treating the patient with FGFRa mUC. Gene expression profiling of FGFRa mUC samples from clinical trials will help determine the potential impact of subtype or other features that may associate with benefit from therapy.

Download Full-text

Trends in Childhood Viable Pregnancy and Risk of Stillbirth in the United States

10.21203/rs.3.rs-167471/v1 ◽

2021 ◽

Author(s):

Sahra Ibrahimi ◽

Deepa Dongarwar ◽

Korede K. Yusuf ◽

Sitratullah Olawunmi Maiyegun ◽

Hamisu M. Salihu

Keyword(s):

Proportional Hazards ◽

Census Data ◽

The United States ◽

Population Based ◽

Cox Proportional Hazards ◽

Early Years ◽

Teen Mothers ◽

Population Census ◽

Hazard Ratios ◽

The Us

Abstract The objective of this study was to assess trends in childhood viable pregnancy over the previous three decades as well as the risk of stillbirth in these highly vulnerable child mothers. We conducted a population-based retrospective cohort study that used Birth datasets, Fetal Death datasets, and the US population census data: 1982-2017. To assess the association between various socio-demographic and maternal comorbidities and stillbirth, we generated adjusted hazard ratios (AHR) from Cox Proportional Hazards Regression models. Overall, there were declines in the stillbirth rates in both teens (15-19 years old) and child mothers aged ≤ 14 years, but the rate remained consistently higher among child mothers. Compared to teen mothers, childhood pregnancy was modestly associated with elevated risk for stillbirth. Childhood pregnancy is a risk factor for stillbirth. These findings further underscore the need for sustained efforts and policies to prevent pregnancies in the early years of reproductive development.

Download Full-text

Long-Term Exposure to Ambient Hydrocarbons Increases Dementia Risk in People Aged 50 Years and above in Taiwan

Current Alzheimer Research ◽

10.2174/1567205017666200103112443 ◽

2020 ◽

Vol 16 (14) ◽

pp. 1276-1289

Author(s):

Han-Wei Zhang ◽

Victor C. Kok ◽

Shu-Chun Chuang ◽

Chun-Hung Tseng ◽

Chin-Teng Lin ◽

...

Keyword(s):

Air Pollutants ◽

Proportional Hazards ◽

The Elderly ◽

Cox Proportional Hazards ◽

Proportional Hazards Regression ◽

Hazard Ratios ◽

Dementia Risk ◽

Disease Exposure ◽

Total Hydrocarbons

Background: Alzheimer’s disease, the most common cause of dementia among the elderly, is a progressive and irreversible neurodegenerative disease. Exposure to air pollutants is known to have adverse effects on human health, however, little is known about hydrocarbons in the air that can trigger a dementia event. Objective: We aimed to investigate whether long-term exposure to airborne hydrocarbons increases the risk of developing dementia. Method: The present cohort study included 178,085 people aged 50 years and older in Taiwan. Cox proportional hazards regression analysis was used to fit the multiple pollutant models for two targeted pollutants, including total hydrocarbons and non-methane hydrocarbons, and estimated the risk of dementia. Results: Before controlling for multiple pollutants, hazard ratios with 95% confidence intervals for the overall population were 7.63 (7.28-7.99, p <0.001) at a 0.51-ppm increases in total hydrocarbons, and 2.94 (2.82-3.05, p <0.001) at a 0.32-ppm increases in non-methane hydrocarbons. The highest adjusted hazard ratios for different multiple-pollutant models of each targeted pollutant were statistically significant (p <0.001) for all patients: 11.52 (10.86-12.24) for total hydrocarbons and 9.73 (9.18-10.32) for non-methane hydrocarbons. Conclusion: Our findings suggest that total hydrocarbons and non-methane hydrocarbons may be contributing to dementia development.

Download Full-text

Contemporary Associations of Exclusive Cigarette, Cigar, Pipe, and Smokeless Tobacco Use With Overall and Cause-Specific Mortality in the United States

JNCI Cancer Spectrum ◽

10.1093/jncics/pkz036 ◽

2019 ◽

Vol 3 (3) ◽

Cited By ~ 4

Author(s):

Maki Inoue-Choi ◽

Meredith S Shiels ◽

Timothy S McNeel ◽

Barry I Graubard ◽

Dorothy Hatsukami ◽

...

Keyword(s):

United States ◽

Tobacco Use ◽

Smokeless Tobacco ◽

Proportional Hazards ◽

The United States ◽

Cox Proportional Hazards ◽

Hazard Ratios ◽

Specific Mortality ◽

Smokeless Tobacco Use ◽

Overall Mortality

Abstract Background A growing proportion of tobacco users in the United States use non-cigarette products including cigars, pipes, and smokeless tobacco. Studies examining the disease and mortality risks of these products are urgently needed. Methods We harmonized tobacco use data from 165 335 adults in the 1991, 1992, 1998, 2000, 2005, and 2010 National Health Interview Surveys. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall and cause-specific mortality occurring through December 31, 2015, were estimated by exclusive use of cigarettes, cigars, pipes, or smokeless tobacco using Cox proportional hazards regression with age as the underlying time metric and never tobacco users as the referent group. Results Current use of cigarettes (HR = 2.23, 95% CI = 2.13 to 2.33) and smokeless tobacco (HR = 1.36, 95% CI = 1.17 to 1.59) were each associated with overall mortality. Relative to never tobacco users, higher risks were observed both in daily (HR = 2.34, 95% CI = 2.24 to 2.44) and nondaily (HR = 1.69, 95% CI = 1.54 to 1.86) cigarette smokers, with associations also observed across major smoking-related causes of death. Daily use of smokeless tobacco was also associated with overall mortality (HR = 1.41, 95% CI = 1.20 to 1.66) as was daily use of cigars (HR = 1.52, 95% CI = 1.12 to 2.08). Current smokeless tobacco use was associated with a higher risk of mortality from heart disease and smoking-related cancer, with strong associations observed for cancers of the oral cavity and bladder. Conclusions Exclusive daily use of cigarettes, cigars, and smokeless tobacco was associated with higher mortality risk. Tobacco control efforts should include cigars and smokeless tobacco.

Download Full-text

Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan

Journal of the American Heart Association ◽

10.1161/jaha.120.019529 ◽

2021 ◽

Author(s):

Peir‐Haur Hung ◽

Chih‐Ching Yeh ◽

Chih‐Yen Hsiao ◽

Chih‐Hsin Muo ◽

Kuan‐Yu Hung ◽

...

Keyword(s):

Renal Disease ◽

End Stage Renal Disease ◽

Proportional Hazards ◽

Cox Proportional Hazards ◽

Proportional Hazards Regression ◽

Defined Daily Doses ◽

Hazard Ratios ◽

Increased Risk ◽

Stage Renal Disease ◽

End Stage

Background Targeting higher hemoglobin levels with erythropoietin to treat anemia in patients with chronic kidney disease is associated with increased cardiovascular risk, including that of stroke. The risks of the subtypes of stroke, ischemic, hemorrhagic, and unspecified, following the administration of erythropoietin in patients with end‐stage renal disease receiving hemodialysis remain unclear. Methods and results Overall, 12 948 adult patients with end‐stage renal disease treated during 1999 to 2010 who had undergone hemodialysis were included. The study end points were the incidences of stroke and its subtypes. We used Cox proportional hazards regression models to estimate hazard ratios (HRs) of stroke and its subtypes in erythropoietin recipients compared with nonrecipients. Patients in the erythropoietin cohort did not have an increased risk of stroke compared with those in the nonerythropoietin cohort (adjusted HR, 1.03; 95% CI, 0.92–1.15). Compared with patients in the nonerythropoietin cohort, the risks of ischemic, hemorrhagic, or unspecified stroke were not higher in patients in the erythropoietin cohort (adjusted HRs, 1.08 [95% CI, 0.93–1.26], 0.96 [95% CI, 0.78–1.18], and 1.03 [95% CI, 0.80–1.32], respectively). Increased risks of stroke and its subtypes were not observed with even large annual defined daily doses of erythropoietin (>201). Conclusions Erythropoietin in patients receiving hemodialysis is not associated with increased risk of stroke or any of its subtypes.

Download Full-text

Comparison of Valvulopathy Risk with Lorcaserin and Phenterminetopiramate for Weight Loss

Current Drug Therapy ◽

10.2174/1574885513666180503141557 ◽

2019 ◽

Vol 14 (1) ◽

pp. 74-78

Author(s):

Michael Guo ◽

Mahyar Etminan ◽

Bruce Carleton

Keyword(s):

Weight Loss ◽

Proportional Hazards ◽

Proportional Hazards Model ◽

Adverse Outcome ◽

The United States ◽

Cox Proportional Hazards ◽

Cox Proportional Hazards Model ◽

Hazards Model ◽

Hazard Ratios ◽

One Year

Background: Lorcaserin and phentermine-topiramate are two drugs marketed for obesity that have shown moderate efficacy after one year of use. However, concerns over risks of serious cardiovascular harms including valvulopathy have been brought up for both drugs, prompting an epidemiologic investigation to quantify this adverse outcome using real-world clinical data. Objective: To compare rates of valvulopathy between the weight-loss drugs lorcaserin and phentermine-topiramate. Methods: A retrospective cohort study using the PharMetrics database from the United States was conducted. From approximately 9 million subjects captured in the database from 2006 to 2016, we identified all patients who had received at least one prescription for lorcaserin or phentermine-topiramate. Users of either drug were followed to the first mutually exclusive diagnosis of non-congenital valvulopathy defined as having received an international classification for diseases, ninth revision clinical modification [ICD-9- CM] code for valvulopathy, or to the end of the study period. A Cox Proportional Hazards model was then constructed to compute adjusted hazard ratios (HRs) to compare the rates of valvulopathy between users of the two drugs. Results: We identified 1,981 lorcaserin users and 1,806 phentermine-topiramate users. Rates of valvulopathy for lorcaserin and phentermine-topiramate cohorts were 26 and 24 per 1000-person-years, respectively. The crude and adjusted hazard ratios (HRs) comparing the two cohorts with respect to valvulopathy were 1.28 (95% CI: 0.73,2.26) and 1.16 (95% CI: 0.65-2.05), respectively. Conclusion: Our analysis suggests comparable rates of valvulopathy between lorcaserin and phentermine-topiramate users. Clinicians are advised to consider the risk of valvular disease when medically managing obesity.

Download Full-text

Suicide in Prison and After Release: A 17-Year National Cohort Study

10.21203/rs.3.rs-236644/v1 ◽

2021 ◽

Author(s):

Anne Bukten ◽

Marianne Riksheim Stavseth

Keyword(s):

Cause Of Death ◽

Proportional Hazards ◽

Prison Population ◽

Cox Proportional Hazards ◽

Proportional Hazards Regression ◽

Hazard Ratios ◽

Crude Mortality ◽

Icd 10 ◽

National Cohort ◽

National Register Data

Abstract BackgroundTo describe all suicides in the Norwegian prison population from 2000 to 2017, during and following imprisonment; to investigate the timing of suicides; and to investigate the associations between risk of suicide and types of crime.Methods.We used data from the Norwegian Prison Release study (nPRIS) including complete national register data from the Norwegian Prison Register and the Norwegian Cause of Death Register in the period 1.1.2000 to 31.12.2016, consisting of 96 856 individuals. All suicides were classified according to ICD-10 codes X60-X84. We calculated crude mortality rates (CMRs) per 100 000 person-years and used a Cox Proportional-Hazards regression model to investigate factors associated with suicide during imprisonment and after release reported as hazard ratios (HRs).ResultsSuicide accounted for about 10% of all deaths in the Norwegian prison population and was the leading cause of death in prison (53% of in deaths in prison). The CMR per 100 000 person years for in-prison suicides was 133.8 and was ten times higher (CMR = 1535.0) on day one of incarceration. Suicides after release (overall CMR = 82.8) also peaked on day one after release (CMR = 665.7). Suicide in prison and after release were both associated with being convicted of murder (HR: 27.41, CI: 3.42-219.63 and HR: 2.79, CI: 1.54–5.06, respectively).ConclusionThere is a high risk of suicide during the immediate first period of incarceration and after release. Convictions for severe violent crime, especially murder, are associated with increased suicide risk, both in prison and after release.

Download Full-text

Adipose Tissue Lipophilic Index and Risk of Ischemic Stroke—A Danish Case-Cohort Study

Nutrients ◽

10.3390/nu10111570 ◽

2018 ◽

Vol 10 (11) ◽

pp. 1570 ◽

Cited By ~ 1

Author(s):

Linda Tram ◽

Stine Krogh Venø ◽

Christina Dahm ◽

Birthe H. Thomsen ◽

Martin Berg Johansen ◽

...

Keyword(s):

Adipose Tissue ◽

Cohort Study ◽

Ischemic Stroke ◽

Proportional Hazards ◽

Cox Proportional Hazards ◽

Fatty Acid Profiles ◽

Unknown Mechanism ◽

Cox Proportional Hazards Regression ◽

Proportional Hazards Regression ◽

Hazard Ratios

Diet may influence the risk of ischemic stroke by several mechanisms. A potential and hitherto unknown mechanism may relate to an effect on the lipophilic index, which is a new and convenient indicator of membrane fluidity. This study investigated the association between the adipose tissue lipophilic index and ischemic stroke and its subtypes. A case-cohort study was conducted based on the Danish cohort study Diet, Cancer, and Health, which includes 57,053 subjects aged 50–64 years at enrolment. A subcohort (n = 3500) was randomly drawn from the whole cohort. All ischemic stroke cases were validated and categorized into subtypes. The lipophilic index was calculated based on fatty acid profiles in adipose tissue. Subjects were divided into quintiles and a weighted Cox proportional hazards regression model was used to calculate hazard ratios. After appropriate exclusions, a subcohort of 3194 subjects and 1752 cases of ischemic stroke were included. When comparing the fifth quintile of the lipophilic index with the first quintile, the hazard ratio for ischemic stroke was 0.92 (95% confidence interval 0.75, 1.13) and the trend across quintiles was not statistically significant (p = 0.1727). In conclusion, no association was found between the lipophilic index and ischemic stroke or its subtypes.

Download Full-text